Skip to content

Arcutis Biotherapeutics

US · ARQT #2465 by market cap Listed 2020
26.36 -0.81 -2.98%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Arcutis Biotherapeutics

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Founded
2016
CEO
Mr. Todd Franklin Watanabe
Employees
354
Headquarters
Westlake Village, California, United States of America
Fiscal year end
12-31
Website
arcutis.com

Company profile

Exchange
US
Symbol
ARQT
Market-cap rank
#2465
Listing date
2020-01-31
Market cap
3.33B
Float cap
2.50B
Shares out
126.46M
Float shares
94.93M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Arcutis Biotherapeutics discussion 0 comments

Add a comment